METTL3 and Alzheimer disease: Compared with the control group, METTL3 expression in the cerebral cortex and hippocampus of AD model mice was upregulated, FTO expression was downregulated, and modification levels were significantly increased, suggesting that m6A methylation promotes AD development (Han et al., 2020).